Dev Drugs (India) Private Limited

Pharmaceutical company manufacturing tablets, capsules, and syrups since 1996.

1996 | Delhi (India) | Active
Last Updated:

Dev Drugs (India) Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.60 M
  • Company Age 28 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.95 Cr
  • Revenue Growth -43.04%
  • Profit Growth -185.76%
  • Ebitda 80.96%
  • Net Worth -17.50%
  • Total Assets -4.74%

About Dev Drugs (India)

Dev Drugs (India) Private Limited (DDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 October 1996 and has a history of 28 years and six months. Its registered office is in Delhi, India.

The Corporate was formerly known as Noni Gopal Infinlease Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.60 M.

The company currently has active open charges totaling ₹5.95 Cr.

Balbir Singh and Subrata Roy serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U65929DL1996PTC082829

  • Company No.

    082829

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    23 Oct 1996

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Dev Drugs (India) Private Limited

Explore comprehensive data for Dev Drugs (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Dev Drugs (India)?

Board Members (2)

NameDesignationAppointment DateStatus
Balbir Singh Country flag representing In Director 15-Sep-2020Current
Subrata Roy Country flag representing In Director 14-Sep-2021Current

Financial Performance of Dev Drugs (India).

Dev Drugs (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.04% decrease. The company also saw a substantial fall in profitability, with a 185.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.5%.

Dev Drugs (India) revenue growth over time
Dev Drugs (India) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-43.04%
Revenue from Operations
-18.12%
Total Assets
-4.74%
Profit or Loss
-185.76%
Net Worth
-17.50%
EBITDA
80.96%

What is the Ownership and Shareholding Structure of Dev Drugs (India)?

In 2023, Dev Drugs (India) had a promoter holding of 93.76% and a public holding of 6.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹59.53 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Sidbi : 5.95 Cr

Latest Charge Details

DateLenderAmountStatus
29 Mar 2023Sidbi₹2.65 CrOpen
30 Mar 2022Sidbi₹2.00 CrOpen
03 Nov 2020Sidbi₹1.30 CrOpen

How Many Employees Work at Dev Drugs (India)?

Dev Drugs (India) has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Dev Drugs (India) Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dev Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Drugs (India)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dev Drugs (India)

Recent activity within the organization

  • Annual General Meeting

    Dev Drugs (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Dev Drugs (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Sidbi amounted to Rs. 26.50 M with Charge ID 100703582 was registered on 29 Mar 2023.

  • Charges

    A charge with Sidbi of Rs. 13.03 M registered on 03 Nov 2020 with Charge ID 100382532 was modified on 25 Mar 2023.

  • Charges

    A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100552164 was registered on 30 Mar 2022.

  • Director Appointment

    Subrata Roy was appointed as a Director was appointed as a Director on 14 Sep 2021 & has been associated with this company since 3 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Dev Drugs (India) Private Limited?

    Dev Drugs (India) Private Limited was incorporated on 23 Oct 1996.

  • What is authorized share capital and paid-up capital of Dev Drugs (India) Private Limited?

    The authorized share capital of Dev Drugs (India) Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.60 M.

  • Who are the current board members & directors of Dev Drugs (India) Private Limited?

    Currently 2 directors are associated with Dev Drugs (India) Private Limited.

    • Balbir Singh
    • Subrata Roy

  • What is the registered address of Dev Drugs (India) Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Dev Drugs (India) Private Limited is D-67 Pandav Nagar, Patparganj India, New Delhi, 110092.

  • What is the corporate identification number (CIN) and company number of Dev Drugs (India) Private Limited?

    The corporate identification number (CIN) of Dev Drugs (India) Private Limited is U65929DL1996PTC082829 and the company number is 082829 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Dev Drugs (India) Private Limited?

    The Official website of Dev Drugs (India) Private Limited is https://www.devdrugs.com

  • What has been the recent revenue trend for Dev Drugs (India) Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Dev Drugs (India) Private Limited has fallen by -43.04%.

  • How many employees does Dev Drugs (India) Private Limited currently have?

    As Per 2023 financial reports, 7 employees are currently employed by Dev Drugs (India) Private Limited.

  • What change has been observed in the net worth of Dev Drugs (India) Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Dev Drugs (India) Private Limited has experienced an downturn of -17.50%.

  • What are the total open charges for Dev Drugs (India) Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Dev Drugs (India) Private Limited amount to ₹ 5.95 Cr.

  • When was the last Balance Sheet of Dev Drugs (India) Private Limited filed with the ROC?

    The most recent Balance Sheet for Dev Drugs (India) Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development